Pasithea Therapeutics Corp (KTTA) Live Share Price, Invest From India

Pasithea Therapeutics Corp Stock Performance

as on November 12, 2026 at 2:59 am IST

Day's Low
Day's High
$0.54
Day's Price Range
$0.57
$0.55
1.84%
Downside
3.62%
Upside
52 Week's Low
52 Week's High
$0.28
52-Week Price Range
$2.06
$0.55
48.92%
Downside
274.48%
Upside

Pasithea Therapeutics Corp share price movements today

Previous Close: $0.57
Open: $0.54
Volume: 308.3K
Market Cap: $19.3M
Day's Low - High: $0.54 - $0.57
52 Week Low - High: $0.28 - $2.06

Pasithea Therapeutics Corp Historical Returns

1 Month Return: + 22.74 %
3 Month Return: + 20.27 %
1 Year Return: -19.18 %
3 Year Return: -92.27 %
5 Year Return: -98.77 %

Pasithea Therapeutics Corp Stock Fundamentals & Key Indicators

Check Pasithea Therapeutics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$19.3M

EPS (TTM)

-2.46

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.23

Industry PE ratio

-3.10

PEG Ratio

-0.00

EBITDA

-23.3M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-49.49%

Pasithea Therapeutics Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pasithea Therapeutics Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Pasithea Therapeutics Corp	Buy	$19.3M	-98.77%	-0.23	0.00%	0.00%
Moderna	Neutral	$101.5B	11.08%	-35.48	28.00%	0.00%
BeOne Medicines	StrongBuy	$46.5B	NA	68.25	88.39%	0.00%
Vertex Pharmaceuticals	StrongBuy	$138.7B	194.77%	34.99	85.57%	0.00%
Regeneron	Buy	$93.5B	46.19%	19.51	85.77%	0.41%

Stock Returns calculator for Pasithea Therapeutics Corp Stock including INR - Dollar returns

The Pasithea Therapeutics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Pasithea Therapeutics Corp investment value today

Current value as on today

₹82,045

Returns

-₹17,955

(-17.96%)

Returns from Pasithea Therapeutics Corp Stock

-₹22,521 (-22.52%)

Dollar Impact

₹4,566 (+4.57%)

Analyst Recommendation on Pasithea Therapeutics Corp Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Pasithea Therapeutics Corp. Average target price of $3

Pasithea Therapeutics Corp Share Price Target

Get share price movements and forecasts by analysts on Pasithea Therapeutics Corp.

What analysts predicted

81.66%UPSIDE

Target Price

Current Price

$0.5501

Analyzed by

7 Analysts

Target

$3.00

Pasithea Therapeutics Corp target price $3, a slight upside of 81.66% compared to current price of $0.5501. According to 7 analysts rating.

Indian Investors' Interest in Pasithea Therapeutics Corp Stock

Search interest for Pasithea Therapeutics Corp Stock has increased by 300% in the last 30 days, reflecting an upward trend in search activity.

Time period: October 12, 2026 to November 11, 2026

Change:300% versus previous 30 day period

Pasithea Therapeutics Corp Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	0	-	-	-	0	0	0
Operating Income	-4	-3	-3	-3	-3	-3	-3	-10	-4	-5
EBITDA	-3	-3	-2	-3	-3	-3	-2	-10	-4	-5
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-3	-3	-2	-3	-3	-3	-3	-10	-2	-5
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-3	-3	-2	-3	-3	-3	-3	-10	-2	-5
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Pasithea Therapeutics Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	0	-	-	-	-
Gross Profit	-	0	0	-	-	-
Operating Income	0	-4	-12	-15	-14	-20
EBITDA	-	-2	-11	-15	-13	-20
Interest Expense	-	0	0	-	-	-
Depreciation	0	0	0	0	0	0
Income Before Tax	0	-2	-11	-15	-13	-20
Income Tax Expense	-	-	-	-	-	-
Net Income	0	-2	-13	-15	-13	-20
Net Profit Margin	0.00%	-14.69%	0.00%	0.00%	0.00%	0.00%

Pasithea Therapeutics Corp Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-3	-3	-2	-3	-3	-3	-3	-10	-2	-8,140
Operating Cash Flow	-4	-4	-3	-2	-3	-3	-2	-5	-4	-4
Investing Cash Flow	-	-	-	-	-	-	-	-	-	-
Financing Cash Flow	-	-	4	0	1	5	0	56	0	0
Change in Cash	-4	-4	1	-2	-1	1	-2	51	-4	-4

Pasithea Therapeutics Corp Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	0	-2	-11	-15	-13	-20
Operating Cash Flow	0	-3	-13	-13	-13	-15
Investing Cash Flow	-	0	-2	0	-	0
Financing Cash Flow	0	55	-3	-3	4	63
Change in Cash	0	52	-19	-16	-9	48

Global Institutional Holdings in Pasithea Therapeutics Corp

Check out the Institutions with significant holdings in Pasithea Therapeutics Corp.

Funds	Holdings
Coastlands Capital LP	11.48%
LAWRENCE STEINMAN	0.60%
VANGUARD INDEX FUNDS	0.38%
Vanguard	0.38%
Fidelity Concord Street Trust	0.24%

See all

Insights on Pasithea Therapeutics Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, KTTA stock has moved up by 8.3%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 849.8% return, outperforming this stock by 869.0%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 258.1% return, outperforming this stock by 350.4%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -2.86M → -5.27M (in $), with an average decrease of 83.8% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 976.30K → 649.02K (in $), with an average decrease of 33.5% per quarter

About Pasithea Therapeutics Corp

Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.

Organisation	Pasithea Therapeutics Corp
Headquarters	1111 Lincoln Road, Miami Beach, FL, 33139, US
Industry	Biotechnology
CEO	Tiago Reis Marques

Key Management of Pasithea Therapeutics Corp

Name	Title
Dr. Kartik Krishnan M.D., Ph.D.	Chief Medical Officer
Dr. Lawrence Steinman BA, M.D., Ph.D.	Co-Founder & Executive Chairman
Dr. Tiago Reis Marques M.D., Ph.D.	CEO & Director
Mr. Daniel H. Schneiderman	Chief Financial Officer

FAQs

What is Pasithea Therapeutics Corp share price today?

Pasithea Therapeutics Corp share price today is $0.55 as on November 11, 2026 at 9:29 pm IST. Pasithea Therapeutics Corp share today touched a day high of $0.57 and a low of $0.54.

What is the 52 week high and 52 week low for Pasithea Therapeutics Corp share?

Pasithea Therapeutics Corp share touched a 52 week high of $2.06 on November 28, 2025 and a 52 week low of $0.28 on November 21, 2025. Pasithea Therapeutics Corp stock price today i.e. November 11, 2026 at 9:29 pm IST is trending at $0.55,which is 73.30% down from its 52 week high and 95.77% up from its 52 week low.

What is Pasithea Therapeutics Corp's market capitalisation today?

Pasithea Therapeutics Corp market capitalisation is $0.00T as on November 11, 2026 at 9:29 pm IST.

How to invest in Pasithea Therapeutics Corp Stock (KTTA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Pasithea Therapeutics Corp on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Pasithea Therapeutics Corp Stock (KTTA) from India?

Indian investors can start investing in Pasithea Therapeutics Corp (KTTA) shares with as little as ₹93.68000030517578 or $1 (as of November 11, 2026 at 9:31 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹936.80 in Pasithea Therapeutics Corp stock (as per the Rupee-Dollar exchange rate as on November 11, 2026 at 9:31 pm IST). Based on Pasithea Therapeutics Corp share’s latest price of $0.55 as on November 11, 2026 at 9:29 pm IST, you will get 18.1785 shares of Pasithea Therapeutics Corp. Learn more about fractional shares .

What are the returns that Pasithea Therapeutics Corp has given to Indian investors in the last 5 years?

Pasithea Therapeutics Corp stock has given -98.77% share price returns and 26.4% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?